<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">gkd476</article-id><article-id pub-id-type="pmid">10931920</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>CHL1</italic> is a nuclear protein with an essential ATP binding site that exhibits a size-dependent effect on chromosome segregation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Holloway</surname><given-names>Sandra L.</given-names></name><xref ref-type="author-notes" rid="N0x98056e0.0x957c950">a</xref></contrib></contrib-group><aff id="N0x98056e0.0x957c970">Howard Hughes Medical Institute, Department of Genetics, University of Pennsylvania, 415 Curie Boulevard, Philadelphia, PA 19104, USA</aff><author-notes><fn id="N0x98056e0.0x957c950"><label>a</label><p>Tel: &#x0002b;1 215 573 9333; Fax: &#x0002b;1 215 573 6325; Email: hollowas&#x00040;mail.med.upenn.edu</p></fn></author-notes><pub-date pub-type="ppub"><day>15</day><month>8</month><year>2000</year></pub-date><volume>28</volume><issue>16</issue><fpage>3056</fpage><lpage>3064</lpage><ext-link ext-link-type="uri" xlink:href="http:&#x0002f;&#x0002f;www.nar.oupjournals.org&#x0002f;content&#x0002f;vol28&#x0002f;issue16&#x0002f;"/><history><date date-type="received"><day>17</day><month>5</month><year>2000</year></date><date date-type="rev-recd"><day>29</day><month>6</month><year>2000</year></date><date date-type="accepted"><day>29</day><month>6</month><year>2000</year></date></history><copyright-statement>Copyright &#x000a9; 2000 Oxford University Press</copyright-statement><copyright-year>2000</copyright-year><abstract><p><italic>Saccharomyces cerevisiae chl1</italic> mutants have a significant increase in the rate of chromosome missegregation. <italic>CHL1</italic> encodes a 99 kDa predicted protein with an ATP binding site consensus, a putative helix&#x02013;turn&#x02013;helix DNA binding motif, and homology to helicases. Using site-directed mutagenesis, I show that mutations that are predicted to abolish ATP binding in <italic>CHL1</italic> inactivate its function in chromosome segregation. Furthermore, overexpression of these mutations interferes with chromosome transmission of a 125 kb chromosome fragment in a wild-type strain. Polyclonal antibodies against <italic>CHL1</italic> show that <italic>CHL1</italic> is predominantly in the nuclear fraction of <italic>S.cerevisiae</italic>. <italic>CHL1</italic> function is more critical for the segregation of small chromosomes. In <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> mutants, artificial circular or linear chromosomes &#x0003c;150 kb in size exhibit near random segregation (0.12 per cell division), whereas all chromosomes tested &#x0003e;225 kb were lost at rates (5 &#x000d7; 10<sup>&#x02013;3</sup> per cell division) comparable to that observed for endogenous chromosome III. These results reveal an important role for ATPases&#x0002f;DNA helicases in chromosome segregation. Such enzymes may alter DNA topology to allow loading of proteins involved in maintaining sister chromatid cohesion.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>The <italic>CHL1</italic> gene product of <italic>Saccharomyces cerevisiae</italic> plays an important role in maintaining a high fidelity of chromosome transmission during mitosis. The original allele, <italic>chl1-1</italic>, was identified in a screen for mutants exhibiting unusual mating phenotypes (<xref ref-type="bibr" rid="gkd476c1">1</xref>). <italic>chl1-1</italic>&#x0002f;<italic>chl1-1</italic> diploids were shown to exhibit a bimating phenotype due to the missegregation of one copy of chromosome III carrying the mating-type locus (<xref ref-type="bibr" rid="gkd476c2">2</xref>). We identified 30 additional alleles of <italic>chl1</italic> in a screen for chromosome transmission fidelity (<italic>ctf</italic>) mutants (<xref ref-type="bibr" rid="gkd476c3">3</xref>) using an assay that monitored the rate of missegregation of a non-essential 145 kb chromosome fragment. The <italic>chl1-1</italic> mutation appeared to cause non-random chromosome loss (<xref ref-type="bibr" rid="gkd476c2">2</xref>), significantly raising the frequency of recovery of 2n-1 diploids monosomic for chromosome III or chromosome I, but not for all chromosomes tested. It has been suggested that these results may indicate a chromosome size-dependent loss phenotype associated with <italic>chl1</italic> mutants. This phenomenon could be related to the increase in mitotic chromosome transmission fidelity observed as a function of increased chromosome length in wild-type cells (4&#x02013;6). <italic>CHL1</italic> is also important for the proper selection of mating type locus, HML or HMR, during mating type switching in yeast (<xref ref-type="bibr" rid="gkd476c7">7</xref>). Rather than selecting the opposite mating type, <italic>Chl1</italic> mutants randomly select mating type (<xref ref-type="bibr" rid="gkd476c7">7</xref>).</p><p>Sequence analysis of a genomic clone of <italic>CHL1</italic> (<xref ref-type="bibr" rid="gkd476c8">8</xref>) revealed a 2.6 kb open reading frame (ORF) encoding a 99 kDa predicted protein with 23&#x00025; identity to the <italic>RAD3</italic> gene (<xref ref-type="bibr" rid="gkd476c9">9</xref>,<xref ref-type="bibr" rid="gkd476c10">10</xref>) involved in nucleotide excision repair in yeast (<xref ref-type="bibr" rid="gkd476c11">11</xref>). Three short domains of high homology between these two genes contained sequence motifs associated with known biochemical functions: an A box and B box consensus found in ATP binding proteins (typically ATPases) (<xref ref-type="bibr" rid="gkd476c12">12</xref>,<xref ref-type="bibr" rid="gkd476c13">13</xref>), and a helix&#x02013;turn&#x02013;helix DNA binding motif (<xref ref-type="bibr" rid="gkd476c14">14</xref>). In addition to this, the <italic>CHL1</italic> sequence contains all seven consensus motifs found in helicases such as the <italic>RAD3</italic> helicase (<xref ref-type="bibr" rid="gkd476c15">15</xref>,<xref ref-type="bibr" rid="gkd476c16">16</xref>). A human homolog of <italic>CHL1</italic> has been identified which is 33&#x00025; identical to <italic>CHL1</italic> and has DNA helicase activity (17&#x02013;20). Purified <italic>RAD3</italic> protein also exhibits single-stranded DNA-dependent ATPase and helicase activities <italic>in vitro</italic> (21&#x02013;23). Furthermore, both of these activities, but not ATP or DNA binding, are abolished by a Lys&#x02192;Arg mutation in the ATP binding site A-box consensus of <italic>RAD3</italic> (<xref ref-type="bibr" rid="gkd476c24">24</xref>). Unlike <italic>RAD3</italic>, none of the 30 <italic>chl1</italic> mutants tested have any detectable defect in DNA synthesis or DNA repair functions (<xref ref-type="bibr" rid="gkd476c2">2</xref>,<xref ref-type="bibr" rid="gkd476c3">3</xref>,<xref ref-type="bibr" rid="gkd476c8">8</xref>). <italic>chl1</italic>&#x00394;<italic>1</italic> null mutants exhibit near wild-type rates of mitotic recombination and a cell cycle delay in G<sub>2</sub>&#x0002f;M which is independent of the <italic>RAD9</italic> DNA damage checkpoint control, but may be dependent on the <italic>MAD</italic> spindle checkpoint (<xref ref-type="bibr" rid="gkd476c8">8</xref>,<xref ref-type="bibr" rid="gkd476c25">25</xref>). Thus, <italic>CHL1</italic> may be a DNA-associated ATPase (or helicase) that is required to ensure chromosome transmission fidelity.</p><p>In this paper, I provide evidence for the importance of the ATP binding site to <italic>CHL1</italic> function and for the prediction that <italic>CHL1</italic> is in the nucleus of <italic>S.cerevisiae</italic>. Site-directed conservative mutations in the putative ATP binding site of <italic>CHL1</italic> disrupt <italic>CHL1</italic> function and form a semi-dominant interfering variant of the <italic>CHL1</italic> protein when overexpressed. Antibodies specific for <italic>CHL1</italic> when used in conjunction with cell fractionation techniques show that <italic>CHL1</italic> is in the nucleus of <italic>S.cerevisiae.</italic> Finally, I have used human DNA containing artificial chromosomes to show that <italic>CHL1</italic> exhibits a size-dependent chromosome missegregation phenotype, providing support for the hypothesis that the non-random chromosome missegregation phenotype originally observed in <italic>chl1-1</italic> is due to a chromosome size-dependent requirement for <italic>CHL1</italic> (<xref ref-type="bibr" rid="gkd476c2">2</xref>).</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Strains</title><p><italic>Escherichia coli</italic> strain CJ236 has the genotype <italic>dut</italic>, <italic>ung</italic>, <italic>thi</italic>, <italic>rel</italic>A1, pCJ105 (<italic>Cm</italic>r). FZ392 is a mutant derivative of LE392 (kindly provided by Richard Janis at Abbott Laboratories, Abbott Park, IL). Strains containing <italic>chl1</italic>&#x00394;<italic>1::TRP1</italic>, <italic>chl1</italic>&#x00394;<italic>1::HIS3</italic> and <italic>chl1</italic>&#x00394;<italic>1::URA3</italic> were constructed by one-step gene replacement as previously described (<xref ref-type="bibr" rid="gkd476c8">8</xref>). In these strains, the first AUG and 1.7 kb of downstream <italic>CHL1</italic> sequence is replaced with pRS304, pRS303 and pRS306, respectively (<xref ref-type="bibr" rid="gkd476c26">26</xref>). All yeast strains are indicated in Table <xref ref-type="table" rid="gkd476tb1">1</xref>.</p></sec><sec><title>Materials</title><p>T4 DNA ligase and T4 DNA polymerase were obtained from New England Biolabs (Beverly, MA). Uridine and lyticase were from Sigma Biochemicals (St Louis, MO). All protease inhibitors were obtained from Boehringer Mannheim Biochemicals (Indianapolis, IN), with the exception of Benzamidine and phenylmethylsulfonyl fluoride which were purchased from Sigma. Zymolyase 60T was obtained from ICN Immunobiologicals (Irvine, CA). The BCA protein determination reagents were obtained from Pierce Biochemicals (Rockford, IL).</p></sec><sec><title>Media</title><p>Media for yeast growth and sporulation were as described (<xref ref-type="bibr" rid="gkd476c27">27</xref>) except that adenine was added at 6 &#x000b5;g&#x0002f;ml to minimal (SD) media to enhance red pigment formation in <italic>ade2</italic> backgrounds (<xref ref-type="bibr" rid="gkd476c4">4</xref>). SG medium is the same as SD medium except that 2&#x00025; galactose replaces 2&#x00025; dextrose.</p></sec><sec><title>Plasmids</title><p>pRS129 (abbreviated to p129 in Figs <xref ref-type="fig" rid="gkd476f3">3</xref> and <xref ref-type="fig" rid="gkd476f4">4</xref>) contains the galactose inducible <italic>GAL1&#x02013;GAL10</italic> promoter (<xref ref-type="bibr" rid="gkd476c28">28</xref>) subcloned into the <italic>Kpn</italic>I site of the <italic>CEN6 ARSH4 TRP1</italic> plasmid pRS314 (<xref ref-type="bibr" rid="gkd476c26">26</xref>). p129C carries a 3.5 kb <italic>Spe</italic>I fragment containing 2.6 kb of <italic>CHL1</italic> predicted ORF, 9 bp of sequence upstream of <italic>CHL1</italic>, and 900 bp of sequence downstream of <italic>CHL1</italic> subcloned into the <italic>Spe</italic>I site of pRS129. p316C contains a 6.0 kb <italic>Not</italic>I&#x02013;<italic>Pst</italic>I fragment derived from pS35 (<xref ref-type="bibr" rid="gkd476c8">8</xref>) and subcloned into the <italic>Not</italic>I&#x02013;<italic>Pst</italic>I sites of the <italic>CEN6 ARSH4 URA3</italic> plasmid pRS316 (<xref ref-type="bibr" rid="gkd476c26">26</xref>). The <italic>Not</italic>I&#x02013;<italic>Pst</italic>I fragment in p316C contains the <italic>CHL1</italic> ORF and flanking genomic DNA sequence, along with &#x0223c;200 bp of pS35-derived polylinker sequence. pATH2C was constructed by cloning the <italic>Spe</italic>I fragment that contains the <italic>CHL1</italic> ORF into the <italic>Xba</italic>I site of pATH2 (<xref ref-type="bibr" rid="gkd476c29">29</xref>,<xref ref-type="bibr" rid="gkd476c30">30</xref>).</p></sec><sec><title>Site-directed mutagenesis</title><p>Plasmid pS4 consists of a 752 bp <italic>Spe</italic>I&#x02013;<italic>Pvu</italic>I fragment of the <italic>CHL1</italic> ORF (<xref ref-type="bibr" rid="gkd476c8">8</xref>) that encompasses the A-box consensus of ATP binding proteins (<xref ref-type="bibr" rid="gkd476c12">12</xref>) subcloned into the <italic>Sma</italic>I site of the phagemid pBluescript KS (Stratagene, La Jolla, CA). Uracil-containing single-stranded pS4-derived template was produced in <italic>E.coli</italic> strain CJ236 infected with helper phage VCS-M13 (Stratagene) essentially as described by the manufacturer. Oligonucleotide-directed mutagenesis was performed using the procedure of Kunkel (<xref ref-type="bibr" rid="gkd476c31">31</xref>). Oligonucleotides (22 bp) with a single mismatch were used to change GGC at position 139 in the <italic>CHL1</italic> nucleotide sequence to GCC or GTC. Similarly, a 21&#x000a0;bp oligonucleotide was used to mutate AAG at position 142 to AGG. These single base changes were confirmed by sequence analysis of the entire 752 bp between <italic>Spe</italic>I and <italic>Pvu</italic>I. Mutations were placed into the full-length, wild-type <italic>CHL1</italic> ORF by replacing the 655 bp <italic>Pfl</italic>M1 fragment in wild-type <italic>CHL1</italic> with the mutant <italic>Pfl</italic>M1 fragment derived from mutagenized pS4. Each of the three mutations generated was subcloned into p129C and p316C.</p></sec><sec><title>Phenotypic analysis of <italic>CHL1</italic> point mutants</title><p>YPH862 (Table <xref ref-type="table" rid="gkd476tb1">1</xref>) carries a deletion of <italic>CHL1</italic> in an <italic>ade2-101</italic> background which allows visual monitoring of the missegregation of a 125 kb non-essential chromosome fragment bearing the ochre suppressing tRNA (<italic>SUP11</italic>) (<xref ref-type="bibr" rid="gkd476c4">4</xref>). YPH862 was transformed selecting Ura<sup>&#x0002b;</sup> (and Trp<sup>&#x0002b;</sup>) by the LiOAc procedure (<xref ref-type="bibr" rid="gkd476c32">32</xref>) with each of the members of the p316-series. Transformants were replated onto medium (containing tryptophan), grown at 30&#x000b0;C, and sectoring frequencies scored. Dominant-negative effects of the <italic>chl1</italic> point mutations were examined in a <italic>CHL1</italic> strain (YPH277) transformed with each of the p129-series and plated onto SG-T (lacking tryptophan) medium.</p></sec><sec><title>Induction and purification of <italic>TrpE</italic>-<italic>CHL1</italic> fusion protein</title><p>Insoluble proteins were prepared as described previously (<xref ref-type="bibr" rid="gkd476c33">33</xref>) from FZ392 <italic>E.coli</italic> (Abbott Labs) strains containing the <italic>TrpE-CHL1</italic> expression vector pATH2C (see above). The <italic>Trp</italic> promoter was activated (<xref ref-type="bibr" rid="gkd476c34">34</xref>) by the addition of indole acrylic acid (<xref ref-type="bibr" rid="gkd476c35">35</xref>) to a final concentration of 10 &#x000b5;g&#x0002f;ml. The <italic>TrpE-CHL1</italic> fusion protein was cut out of preparative SDS&#x02013;PAGE gels stained with 3 M copper sulfate (<xref ref-type="bibr" rid="gkd476c36">36</xref>), and the gel slice was macerated and sent to Hazelton Couance Company (Denver, PA) for the production of antibodies.</p></sec><sec><title>Western analysis and cellular fractionation</title><p>Cultures of YPH491 transformed with pRS129 (YPH851) or p129C (YPH852) were grown in 2&#x00025; galactose to induce Chl1 expression and then fractionated into nuclear and post-nuclear fractions as previously described (<xref ref-type="bibr" rid="gkd476c37">37</xref>). Cellular protein fractions (and whole yeast cells) were extensively sonicated and boiled in Laemmli buffer to ensure maximal solubilization of proteins. Total protein concentration in these solubilized fractions was determined after a TCA DOC protein precipitation to remove interfering substances (38&#x02013;42). Protein representative of equal numbers of cells from each fraction was loaded by assuming 100&#x00025; yield of each fraction. The nuclear protein is therefore most likely to be underrepresented. Western blot analysis was performed using standard procedures (<xref ref-type="bibr" rid="gkd476c43">43</xref>) except that 0.01&#x00025; sodium dodecyl sulfate was added to the western transfer buffer to replace methanol. The D77 nucleolar antibodies were a kind gift of Dr John P. Aris.</p></sec><sec><title>Affinity purification of <italic>CHL1</italic> antibodies</title><p><italic>CHL1</italic> antibodies were affinity purified from <italic>CHL1-TrpE</italic> fusion protein that was immobilized on nitrocellulose, using an acid shock treatment essentially as described (<xref ref-type="bibr" rid="gkd476c44">44</xref>). A 100 kDa protein was recognized in strains overexpressing <italic>CHL1</italic> protein, but not in strains expressing wild-type levels of <italic>CHL1</italic> (data not shown). Identical results were obtained with affinity purified antibodies derived from the sera of both rabbits (data not shown).</p></sec><sec><title>Chromosome missegregation rate calculations</title><p>Half sector analysis of various artificial chromosome constructs (linear or circular, containing yeast, plasmid or human DNA) was performed as previously described (<xref ref-type="bibr" rid="gkd476c4">4</xref>,<xref ref-type="bibr" rid="gkd476c45">45</xref>). Chromosome missegregation rates of <italic>SUP11</italic>-containing constructs lost too frequently to score by half sector analysis were calculated by fluctuation analysis essentially as described (<xref ref-type="bibr" rid="gkd476c46">46</xref>). Approximately 200 cells from each of seven to 10 colonies were replated for each mutant and visually scored for presence of the chromosome fragment. Rates were calculated by the method of the median (<xref ref-type="bibr" rid="gkd476c47">47</xref>). All circular artificial chromosomes were as described previously (<xref ref-type="bibr" rid="gkd476c4">4</xref>). YCp50 is a 10 kb pBR322-derived circular minichromosome. The 75 kb yeast artificial chromosome (YAC; in YPH871 and YPH872), 225&#x000a0;kb YAC (in YPH873 and YPH874) and 360 kb YAC (in YPH875 and YPH876) are serial deletion derivatives (<xref ref-type="bibr" rid="gkd476c48">48</xref>) of the distal arm of a 365 kb human DNA-derived YAC (in YPH516). The sizes of all YACs were confirmed by OFAGE gel analysis (data not shown).</p></sec></sec><sec><title>RESULTS</title><sec><title>Nuclear localization of <italic>CHL1</italic></title><p>Attempts to interpret <italic>CHL1</italic> localization to nuclei in whole yeast cells by immunofluorescence with affinity-purified <italic>CHL1</italic> antibodies were ambiguous due to a weak nuclear signal in <italic>chl1</italic>&#x00394;<italic>1</italic> strains. I, therefore, took advantage of a nuclear purification technique (<xref ref-type="bibr" rid="gkd476c37">37</xref>) to determine the localization of <italic>CHL1</italic> in yeast cells. Cytoplasmic (post-nuclear supernatant) and nuclear extracts were made from a protease-deficient strain grown under conditions leading to <italic>GAL1</italic>-driven overproduction of <italic>CHL1</italic> (YPH 852). Cytoplasmic and nuclear fractions from equal numbers of cells were separated by SDS&#x02013;PAGE and analyzed for the presence of <italic>CHL1</italic> or a control nucleolar protein (D77) by western analysis (Fig. <xref ref-type="fig" rid="gkd476f1">1</xref>). The 39 kDa D77 nucleolar antigen was present in nuclear subcellular fractions (Fig. <xref ref-type="fig" rid="gkd476f1">1</xref>A, lane 2), but not in cytoplasmic subcellular fractions (Fig. <xref ref-type="fig" rid="gkd476f1">1</xref>A, lane 1) of cells expressing elevated (Fig. <xref ref-type="fig" rid="gkd476f1">1</xref>) or wild-type levels of <italic>CHL1</italic> (data not shown). A similar subcellular distribution was found using affinity-purified <italic>CHL1</italic> antibodies (Fig. <xref ref-type="fig" rid="gkd476f1">1</xref>B). A 100 kDa <italic>CHL1</italic>-specific band was detected in nuclear extracts (Fig. <xref ref-type="fig" rid="gkd476f1">1</xref>B, lane 2), and is weakly detectable in cytoplasmic fractions (Fig. <xref ref-type="fig" rid="gkd476f1">1</xref>B, lane 1) made from a strain overexpressing <italic>CHL1</italic>. It is not detectable in any of the fractions from a strain expressing wild-type levels of <italic>CHL1</italic> (not shown). A 67 kDa cross reacting band is present in western blots analyzed with either <italic>CHL1</italic> or D77 antibodies. This band is also present in cells completely lacking <italic>CHL1</italic> and is probably due to non-specific antibody binding to an antigen of this size. I conclude that <italic>CHL1</italic> is located predominantly in the nucleus of <italic>S.cerevisiae</italic>. Its low abundance in the cytoplasmic fraction may indicate a role for <italic>CHL1</italic> in the cytoplasm in addition to the nucleus, may simply be due to overexpression of Chl1 or may be due to leakage of Chl1 from nuclei when extracts are made.</p></sec><sec><title>Conservative mutations in the ATP binding site consensus of <italic>CHL1</italic> disrupt <italic>CHL1</italic> function</title><p>To determine whether the putative ATP binding site was important for <italic>CHL1</italic> function, I made site-directed changes in highly conserved residues of the ATP binding site of <italic>CHL1</italic> (Fig. <xref ref-type="fig" rid="gkd476f2">2</xref>A, &#x02018;C&#x02019;) and analyzed the phenotypes of strains carrying these mutations on a plasmid. All amino acid changes maintained the charge approximate size, and hydrophobic character of the wild-type amino acid. Gly47 of <italic>CHL1</italic> was changed to Ala or Val, and Lys48 was changed to Arg (Fig. <xref ref-type="fig" rid="gkd476f2">2</xref>A, &#x02018;CGA, CGV and CKR&#x02019;, respectively). Single copy (<italic>CEN ARS</italic>) plasmids were made which allowed either <italic>CHL1</italic>-promoter driven synthesis (p316-series), or <italic>GAL1</italic>-driven overexpression (p129-series) of <italic>CHL1</italic> point mutant derivatives (see Materials and Methods).</p><p>To determine whether the ATP binding site mutants retained <italic>CHL1</italic> activity, the p316-series of constructs (<italic>CHL1</italic> promoter-driven) were transformed into a <italic>chl1</italic> deletion mutant carrying a 125 kb non-essential chromosome fragment for monitoring chromosome transmission fidelity (<xref ref-type="bibr" rid="gkd476c4">4</xref>,<xref ref-type="bibr" rid="gkd476c45">45</xref>). Wild-type (p316C) <italic>CHL1</italic> was able to fully complement the dramatic chromosome missegregation phenotype of <italic>chl1</italic>&#x00394;<italic>1</italic> mutants (Fig. <xref ref-type="fig" rid="gkd476f2">2</xref>B). Vector alone (p316) and plasmid constructs carrying each of the three ATP binding site mutations (p316CGA, p316CGV and p316CKR) were unable to complement the chromosome transmission defect of <italic>chl1</italic>&#x00394;<italic>1</italic> (Fig. <xref ref-type="fig" rid="gkd476f2">2</xref>B).</p><p>I also determined whether overexpression of <italic>CHL1</italic> ATP binding site mutants (p129-series) could rescue the <italic>chl1</italic>&#x00394;<italic>1</italic> chromosome fragment missegregation phenotype. Only strains overexpressing wild-type <italic>CHL1</italic>, but none of the mutants, could complement the <italic>chl1</italic>&#x00394;<italic>1</italic> mutation (data not shown). Western analysis (Fig. <xref ref-type="fig" rid="gkd476f3">3</xref>) revealed that the <italic>chl1</italic> and <italic>CHL1</italic> proteins were being made. A 100 kDa band was clearly detectable in extracts from cells overexpressing <italic>CHL1</italic> (lane 7), and to various extents in extracts overexpressing each of the three <italic>chl1</italic> mutant constructs (lanes 1, 3 and 5). This 100 kDa band could not be detected in extracts from cells containing vector alone (lanes 9 and 10), or those grown in dextrose (lanes 2, 4, 6 and 8). Thus, the <italic>CHL1</italic> ATP binding site mutant proteins are being expressed, but they do not possess <italic>CHL1</italic> function. I conclude that the ATP binding site of <italic>CHL1</italic> is essential to <italic>CHL1</italic> function.</p></sec><sec><title><italic>CHL1</italic> ATP binding site mutants exhibit a dominant-negative effect on chromosome transmission</title><p>Changes in the GKT consensus of some nucleotide binding proteins have created functionally altered proteins with dominant interfering biological effects (<xref ref-type="bibr" rid="gkd476c49">49</xref>). I therefore analyzed whether ATP binding site mutations in <italic>CHL1</italic> could interfere with chromosome transmission in a <italic>CHL1</italic> strain. YPH277 is a <italic>CHL1</italic> strain that carries a 125 kb non-essential chromosome fragment in a background designed to monitor the chromosome missegregation rate of the fragment by a colony color sectoring assay (<xref ref-type="bibr" rid="gkd476c4">4</xref>). This strain was transformed with the p129-series (<italic>GAL1</italic> promoter driven constructs) and transformants were analyzed for any chromosome segregation defects associated with <italic>CHL1</italic> mutant overexpression. The fidelity of chromosome transmission was not affected by overexpression of <italic>CHL1</italic> on p129C, or the presence of the vector (p129) alone (Fig. <xref ref-type="fig" rid="gkd476f4">4</xref>). Overexpression of each of the point mutant alleles of <italic>CHL1</italic>, especially the Lys47&#x02192;Arg47 mutation, interfered with the fidelity of transmission of the 125 kb chromosome fragment (Fig. <xref ref-type="fig" rid="gkd476f4">4</xref>). This effect was not detectable in strains transformed with a <italic>CEN ARS</italic> vector carrying these point mutations expressed from the <italic>CHL1</italic> promoter (data not shown). This and the above data suggest that ATP binding site mutant proteins of <italic>CHL1</italic> are still competent to bind a protein or DNA in wild-type cells but that the lack of ATPase activity causes the mutant protein to interfere directly or indirectly with the process of chromosome segregation.</p></sec><sec><title>Null alleles of <italic>CHL1</italic> destabilize circular chromosomes</title><p>Previous work (<xref ref-type="bibr" rid="gkd476c8">8</xref>,<xref ref-type="bibr" rid="gkd476c50">50</xref>) has shown that the absence of <italic>CHL1</italic> function has a dramatic effect on the fidelity of transmission of linear chromosomes, including chromosome III. I analyzed the effect of a <italic>chl1</italic> null mutant on the segregation of a circular derivative of chromosome III. I reasoned that if <italic>CHL1</italic> plays a role in telomere structure or function, I might expect the transmission fidelity of circular chromosomes (which lack telomeres) to be unaffected in <italic>chl1</italic> mutants. Chromosome missegregation rates were determined for a <italic>SUP11</italic>-marked 335 kb circular derivative of chromosome III (<xref ref-type="bibr" rid="gkd476c4">4</xref>,<xref ref-type="bibr" rid="gkd476c50">50</xref>) using half-sector analysis (<xref ref-type="bibr" rid="gkd476c4">4</xref>). In <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> (wild-type) diploids this circular chromosome is lost at a rate of 4.2 &#x000d7; 10<sup>&#x02013;4</sup> per cell division (Table <xref ref-type="table" rid="gkd476tb2">2</xref>), and in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> mutant diploids it is lost at a rate of 1.2 &#x000d7; 10<sup>&#x02013;3</sup>. Therefore, the <italic>chl1</italic>&#x00394;<italic>1</italic> mutation has a minor but measurable effect on circular chromosome III, increasing its missegregation rate 3-fold. Despite this small fold effect, the missegregation rate of circular chromosome III in <italic>chl1</italic>&#x00394;<italic>1</italic> strains was raised to the same level as that observed for natural chromosome III in <italic>chl1</italic>&#x00394;<italic>1</italic> strains (Table <xref ref-type="table" rid="gkd476tb2">2</xref>).</p><p>I also analyzed the chromosome missegregation rates of circular artificial chromosomes of different sizes in <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> and <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploid strains using half sector- and fluctuation analysis (see Materials and Methods). Consistent with previously published results (<xref ref-type="bibr" rid="gkd476c4">4</xref>,<xref ref-type="bibr" rid="gkd476c5">5</xref>), larger circular artificial chromosomes are more stable in wild-type strains (Table <xref ref-type="table" rid="gkd476tb2">2</xref>). The 10, 50 and 100 kb chromosomes showed missegregation rates of 7.9 &#x000d7; 10<sup>&#x02013;2</sup>, 9.0 &#x000d7; 10<sup>&#x02013;3</sup> and 4.6 &#x000d7; 10<sup>&#x02013;3</sup> per cell division, respectively (Table <xref ref-type="table" rid="gkd476tb2">2</xref>). However, in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> mutants, all three circular artificial chromosomes missegregate at the same high rate of 0.15 missegregation events per cell division (Table <xref ref-type="table" rid="gkd476tb2">2</xref>). Thus, <italic>CHL1</italic> is essential to the transmission of circular chromosomes, suggesting that it does not strictly play a role in telomere maintenance.</p></sec><sec><title>Effect of size on missegregation rates of linear chromosomes in a <italic>chl1</italic> null mutant</title><p>It has been observed that <italic>chl1-1</italic> generates 2n-1 karyotypes with a bias towards missegregation of the smaller chromosomes (<xref ref-type="bibr" rid="gkd476c2">2</xref>,<xref ref-type="bibr" rid="gkd476c50">50</xref>). I wanted to distinguish between a possible chromosome size-dependent requirement for <italic>CHL1</italic> and lethality or slow growth associated with specific aneuploidies. To do this systematically, I took advantage of the availability of human DNA-based non-essential YACs of different sizes. The absence of yeast DNA in these chromosomes circumvents any potential for gene dosage associated toxicity which might bias missegregation rates for particular chromosomes. All YACS used were sequential deletion derivatives (<xref ref-type="bibr" rid="gkd476c48">48</xref>) of a 365 kb YAC. The short arm of the YAC is &#x0223c;10 kb in length and contains a yeast auxotrophic marker, <italic>ARSH4</italic>, <italic>SUP11</italic> and yeast telomeric sequences. The long arm consists of &#x0223c;340 kb of human DNA with a yeast auxotrophic marker and yeast telomeric sequences at its end. Deletion derivatives of this YAC sequentially delete sequences from the telomere on the long arm.</p><p>Chromosome missegregation rates were determined (see Materials and Methods) for a 75, 225 and 360 kb YAC in <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> and <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids (Table <xref ref-type="table" rid="gkd476tb2">2</xref>). In <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> diploids, the missegregation rates of the 75, 225 and 360&#x000a0;kb YACs were 4.2 &#x000d7; 10<sup>&#x02013;4</sup>, 4.9 &#x000d7; 10<sup>&#x02013;4</sup> and 2.7 &#x000d7; 10<sup>&#x02013;3</sup> per cell division, respectively (Table <xref ref-type="table" rid="gkd476tb2">2</xref>). In <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids the 75 kb YAC was destabilized 340-fold to a level approaching random segregation. In contrast, the 225 and 360&#x000a0;kb YACs were destabilized 8- and 3-fold, respectively, to missegregation rates of 3.8 &#x000d7; 10<sup>&#x02013;3</sup> and 7.3 &#x000d7; 10<sup>&#x02013;3</sup>, approaching that previously observed for the missegregation of endogenous chromosome III in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids (Table <xref ref-type="table" rid="gkd476tb2">2</xref>) (<xref ref-type="bibr" rid="gkd476c8">8</xref>). Although the analysis of the fold increase in chromosome missegregation rates in <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> versus <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids is complicated (see Discussion), the analysis of the absolute missegregation rates in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids for the various chromosomes is more clear. These results suggest that the lack of <italic>CHL1</italic> cripples the segregation of a small chromosome to the point that it almost segregates randomly. In contrast, the lack of <italic>CHL1</italic> affects the segregation of larger chromosomes more moderately.</p><p>We showed previously that the 365 kb full-length chromosome III missegregates at a rate of 1.5 &#x000d7; 10<sup>&#x02013;5</sup> in <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> cells and is destabilized 210-fold in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids, to a missegregation rate of 3 &#x000d7; 10<sup>&#x02013;3</sup> (<xref ref-type="bibr" rid="gkd476c8">8</xref>). To determine the effect of deleting <italic>CHL1</italic> on smaller chromosome III derivatives, I measured the chromosome missegregation rates of a 145 kb chromosome fragment in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> and <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> strains. This chromosome fragment exhibited a chromosome missegregation rate of 4 &#x000d7; 10<sup>&#x02013;4</sup> in <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> strains. In <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> strains, however, the chromosome missegregation rate rose dramatically (3000-fold) to 1 &#x000d7; 10<sup>&#x02013;1</sup> (Table <xref ref-type="table" rid="gkd476tb2">2</xref>) (<xref ref-type="bibr" rid="gkd476c8">8</xref>). Once again, this suggests that the loss of <italic>CHL1</italic> affects the segregation of smaller chromosomes more than larger chromosomes.</p></sec></sec><sec><title>DISCUSSION</title><p>The <italic>CHL1</italic> gene product is critical to the high fidelity of mitotic chromosome transmission. Although <italic>CHL1</italic> is not essential for viability, <italic>chl1</italic> mutants exhibit extremely high rates of sister chromatid missegregation. Our previous work (<xref ref-type="bibr" rid="gkd476c8">8</xref>) suggested that the <italic>CHL1</italic> gene product acts as an ATP binding protein that functions after DNA synthesis and before the completion of mitosis. In the present work, I present experimental support for the importance of the putative ATP binding site, localize the <italic>CHL1</italic> gene product to the nucleus, and analyze the effect of chromosome length and structure on the <italic>chl1</italic>&#x00394;<italic>1</italic>-associated chromosome missegregation phenotype.</p><p>Conservative site-directed changes (Gly47 to Ala or Val, and Lys48 to Arg) made in the predicted ATP binding site A-box consensus of <italic>CHL1</italic> inactivated its chromosome transmission fidelity function. Mutations within these three highly conserved amino acids (GKT&#x0002f;S) of known ATP and GTP binding proteins generally alter the biological function of the protein (<xref ref-type="bibr" rid="gkd476c49">49</xref>,51&#x02013;55). Changes identical to those introduced into <italic>CHL1</italic> which maintain the approximate size, charge and hydrophobic characteristics of the wild-type amino acid residue have been introduced into the <italic>mdr</italic> (<xref ref-type="bibr" rid="gkd476c51">51</xref>) and <italic>RAD3</italic> (<xref ref-type="bibr" rid="gkd476c24">24</xref>) genes. A Gly&#x02192;Ala mutation or a Lys&#x02192;Arg mutation in either of the two ATP binding site A-box consenses in <italic>mdr</italic> abolishes its ability to confer multidrug resistance, yet retains the ability of the protein to bind ATP (<xref ref-type="bibr" rid="gkd476c51">51</xref>). A Lys&#x02192;Arg mutation in the A-box consensus of <italic>RAD3</italic> abolishes its ATPase and helicase activities, but also still allows ATP and DNA binding. Thus, proteins with these conservative ATP binding site mutations appear to retain wild-type structure to the extent that they can bind ATP, yet biological functions which depend on the energy of hydrolysis of ATP are prevented. Proteins with these characteristics may form irreversible associations in the absence of ATP hydrolysis and thus act as dominant interfering mutants. For example, a Lys&#x02192;Asn mutation in the GKT amino acid consensus of the Ha-<italic>ras</italic> GTPase causes a dominant temperature-dependent lethality in <italic>S.cerevisiae</italic> (<xref ref-type="bibr" rid="gkd476c49">49</xref>). Similarly, Chl1 proteins containing mutations in the ATP binding site exhibited no detectable <italic>CHL1</italic> function. Furthermore, these ATP binding site mutations in <italic>CHL1</italic> exhibited a dominant-negative effect on chromosome segregation when overexpressed in wild-type cells. These results suggest that the ATP binding site in <italic>CHL1</italic> is essential to the role of <italic>CHL1</italic> in chromosome segregation. Furthermore, by drawing a parallel between the <italic>mdr</italic>, <italic>rad3</italic> and <italic>chl1</italic> ATP binding site point mutant data and sequence homologies between these proteins, I suggest that the <italic>CHL1</italic> ATP binding site mutants retain partial <italic>CHL1</italic> structure, and may bind their normal substrate (DNA perhaps). Once bound, however, ATPase- (or helicase-)defective Chl1 protein may then hinder the recognition or loading of protein complexes essential for proper chromosome segregation during mitosis. Several explanations could account for the need to overexpress <italic>CHL1</italic> point mutants to observe a dominant phenotype. For example, the interacting component may be relatively abundant. Alternatively, the association of <italic>CHL1</italic> with this component may be weak, or transient (if <italic>CHL1</italic> is an ATPase), or the fraction of mutant <italic>chl1</italic> protein that is interaction-competent may be small.</p><p>A <italic>chl1</italic>&#x00394;<italic>1</italic> mutation causes dramatic increases in the missegregation rates of small (&#x0003c;100 kb) circular artificial chromosomes, showing that structures that lack telomeres still have a requirement for <italic>CHL1</italic> function for accurate chromosome segregation. Furthermore, a <italic>chl1</italic> deletion mutant exhibits no measurable effect on telomere length (F.Spencer and V.Lundbladt, unpublished data). These results suggest that <italic>CHL1</italic> does not play a role in telomere structure.</p><p>I have attempted to determine if <italic>chl1</italic> mutants exhibit a chromosome-size dependent effect on the missegregation rates of yeast chromosomes, as previously suggested by Liras and colleagues (<xref ref-type="bibr" rid="gkd476c2">2</xref>,<xref ref-type="bibr" rid="gkd476c50">50</xref>). First, I measured the chromosome missegregation rates of three related YACs of different sizes (75, 225 and 360 kb) in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> and <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> strains. Then, I measured the missegregation rates of a 145 kb chromosome fragment derivative of endogenous yeast chromosome III in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> and <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> strains and compared that to our published chromosome missegregation rate for the 365 kb full-length endogenous chromosome III in the same strains (Table <xref ref-type="table" rid="gkd476tb2">2</xref>) (<xref ref-type="bibr" rid="gkd476c8">8</xref>).</p><p>Two numerical values emerge from our studies of chromosome missegregation in these strains (Table <xref ref-type="table" rid="gkd476tb2">2</xref>): the absolute missegregation rates of chromosomes of different sizes in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> strains, and the fold effect on chromosome missegregation caused by deleting <italic>CHL1</italic> (rate in <italic>chl1</italic> mutants&#x0002f;rate in wild-type cells).</p><p>When one focuses on the absolute missegregation rates, a clear trend emerges (Table <xref ref-type="table" rid="gkd476tb2">2</xref>). In <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> strains the larger 225 and 360 kb YACs and 365 kb endogenous chromosome are still able to segregate quite well, with average missegregation rates of 5 &#x000d7; 10<sup>&#x02013;3</sup> per cell division. In contrast, however, in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> strains the smaller 75 kb YAC and 145 kb chromosome III derivative segregate very poorly, with average missegregation rates of 0.12 per cell division. Thus, deleting <italic>CHL1</italic> results in more severe defects in the segregation of small chromosomes than large chromosomes.</p><p>When one focuses on the fold effect on chromosome missegregation caused by deleting <italic>CHL1</italic>, the analysis is more complex (Table <xref ref-type="table" rid="gkd476tb2">2</xref>). In wild-type cells the 225 and 360 kb YACs were less stable than the shorter 75 kb YAC. The relative instability of the two larger YACs was a surprise to us, since previous studies with &#x003bb; DNA-based YACs showed that larger chromosomes were more stable than smaller chromosomes (4&#x02013;6). A significant difference between these studies and my study lies in the length of the chromosome arm containing the foreign DNA insert (&#x0003c;150 kb, in contrast to 225 and 360 kb in our study). Thus, the relative instability in wild-type cells of our longer human YACs may be related to difficulties associated with replicating and segregating long chromosome arms composed of foreign DNA. The loss of <italic>CHL1</italic> had a small fold effect on these two YACs (3&#x02013;8-fold). This may be because <italic>CHL1</italic> acts in the same pathway that is already defective in these YACs. In contrast to the unusual missegregation behavior of the two long YACs in wild-type cells, the smaller 75 kb YAC, the 145 kb chromosome III fragment and the 365 kb chromosome III behaved as expected from the literature. They exhibited missegregation rates that decreased with increasing size, and these missegregation rates were close to those measured for similar-sized chromosomes in the literature (4&#x02013;6,56&#x02013;59). Deletion of <italic>CHL1</italic> had a similar and large fold effect (200&#x02013;3000-fold) on these three chromosomes (Table <xref ref-type="table" rid="gkd476tb2">2</xref>).</p><p>Why does deleting <italic>CHL1</italic> have similar fold effect on chromosomes of all sizes yet have such a significant effect on the absolute missegregation rate of small chromosomes? The lack of <italic>CHL1</italic> may cause a similar defect on all chromosomes. However, this defect may be additive (or synergistic) with a <italic>cis</italic> defect already associated with small chromosomes, and that causes smaller chromosomes to missegregate more often than large chromosomes in wild-type cells (4&#x02013;6,<xref ref-type="bibr" rid="gkd476c56">56</xref>).</p><p>There is some evidence for <italic>cis</italic> defects in small chromosomes. First, very short chromosomes (&#x0223c;15 kb) have irreparable defects that activate the spindle damage checkpoint (<xref ref-type="bibr" rid="gkd476c60">60</xref>). The exact nature of this defect is not yet known. However, it must affect the mitotic spindle or chromosome structure, and alter the forces on the kinetochore during metaphase chromosome alignment, since these are the types of defects that activate the spindle checkpoint (61&#x02013;64). I do not know if my 75 kb human DNA based YAC or 145 kb chromosome III derivatives activate the spindle checkpoint. Second, chromosomes below a size threshold of &#x0223c;200 kb, may not have, or may not be able to maintain, sister chromatid intercatenation after DNA replication (<xref ref-type="bibr" rid="gkd476c65">65</xref>,<xref ref-type="bibr" rid="gkd476c66">66</xref>). These intercatenanes may be required, in conjunction with protein complexes such as the &#x02018;cohesins&#x02019; (<xref ref-type="bibr" rid="gkd476c67">67</xref>), to hold sister chromatids together until the metaphase to anaphase transition (<xref ref-type="bibr" rid="gkd476c5">5</xref>,<xref ref-type="bibr" rid="gkd476c68">68</xref>,<xref ref-type="bibr" rid="gkd476c69">69</xref>). At this transition, only associated sisters with bipolar spindle attachment will segregate accurately during the ensuing anaphase. If these intercatenanes are not present in chromosomes &#x0003c;200 kb, then they will be more sensitive to defects in the sister chromatid cohesion complex, leading to a greater missegregation frequency in wild-type cells, and significant missegregation rates in mutants that affect that complex.</p><p>If removing <italic>CHL1</italic> is additive (or synergistic) with these types of <italic>cis</italic> defects in small chromosomes, what role might Chl1 play during chromosome segregation? It is intriguing that the chromosome size range below which removing <italic>CHL1</italic> causes almost random chromosome segregation, coincides with the size range within which sister chromatids may no longer be held together by intercatenation. Perhaps <italic>CHL1</italic> normally regulates some function that compensates for the absence of intercatenation of small chromosomes. One model that can be tested is that Chl1 acts as a helicase that modifies DNA structure during the establishment or maintenance of sister chromatid cohesion.</p></sec></body><back><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="gkd476f1"><label>Figure 1</label><caption><p> Localization of <italic>CHL1</italic> protein by western analysis of cell fractions. Whole yeast cells overexpressing <italic>CHL1</italic> were fractionated into nuclear (lanes 2) and cytoplasmic (lanes 1) fractions. Protein extract representative of equal cell numbers was loaded in each lane and subject to western analysis with D77 antiserum in (<bold>A</bold>) or affinity purified RJH87 anti-<italic>CHL1</italic> antiserum in (<bold>B</bold>). Positions of molecular weight markers are indicated on the left.</p></caption><graphic xlink:href="gkd47601"/></fig><fig id="gkd476f2"><label>Figure 2</label><caption><p> (<bold>A</bold>) ATP binding site point mutations made in <italic>CHL1</italic>. (<bold>B</bold>) Analysis of <italic>CHL1</italic> function of ATP binding site mutants using the colony color sectoring assay. A <italic>chl1</italic>&#x00394;<italic>1</italic> null haploid strain (YPH862) was transformed with the plasmid constructs indicated and transformants were plated to visualize their chromosome missegregation phenotype by the colony color sectoring assay. p316 is vector alone. The p316-series of plasmid constructs carry wild-type or ATP binding site point mutants of <italic>CHL1</italic> driven by their own promoter on a single copy <italic>CEN ARS</italic> plasmid pRS316 (26).</p></caption><graphic xlink:href="gkd47602"/></fig><fig id="gkd476f3"><label>Figure 3</label><caption><p><italic>Gal1</italic> promoter directed overexpression of <italic>CHL1</italic> point mutant proteins carried on the p129-series of constructs. Western analysis was performed with affinity purified <italic>CHL1</italic> antiserum on cell extracts made from YPH491 cells transformed with pRS129 (lanes 9 and 10), p129C (lanes 7 and 8), p129CGA (lanes 5 and 6), p129CGV (lanes 3 and 4) and p129CKR (lanes 1 and 2). Transformants were grown in dextrose (lanes 1, 3, 5, 7 and 9) or galactose (lanes 2, 4, 6, 8 and 10). Western analysis was performed with affinity-purified RJH87 antiserum. Positions of molecular weight markers are indicated on the left.</p></caption><graphic xlink:href="gkd47603"/></fig><fig id="gkd476f4"><label>Figure 4</label><caption><p> Analysis of dominant-negative phenotype of ATP binding site point mutants. A <italic>CHL1</italic> haploid (YPH277) was transformed with the plasmid constructs indicated and transformants were replated on galactose plates to induce <italic>GAL1</italic> promoter driven overexpression of ATP binding site mutants of <italic>CHL1</italic>. Chromosome transmission fidelity of a 125 kb chromosome fragment was assessed by the colony color sectoring assay. ATP binding site mutant alleles on p129CGA, p129CKR and wild-type <italic>CHL1</italic> on p129C are as indicated in Figure 2A. YPH277 transformed with p129CGV is similar in phenotype to p129CGA under these conditions (data not shown).</p></caption><graphic xlink:href="gkd47604"/></fig><table-wrap id="gkd476tb1"><label>Table 1.</label><caption><title>Yeast strains used in this study</title></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col/><col/></colgroup><tbody valign="top"><tr valign="top"><td valign="top">YPH277<hr/></td><td valign="top">MATa <italic>ura3-52 lys2-801 ade2-101 trp1</italic>&#x00394;<italic>1 leu2</italic>-&#x00394;<italic>1 CFVII (RAD2.d.YPH277) URA3 SUP11</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH491<hr/></td><td valign="top"><italic>MATa ura3-52 his3</italic>-&#x00394;<italic>1 leu2</italic>-&#x00394;<italic>1 trp1D63 prbl-1122 pep4-3 prcl 407</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH516<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 leu2</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 LAC (H.365kb.YPH425) CEN4 URA3 SUP11 TRP1</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH851<hr/></td><td valign="top">YPH491 transformed with pRS129<hr/></td></tr><tr valign="top"><td valign="top">YPH852<hr/></td><td valign="top">YPH491 transformed with p129C<hr/></td></tr><tr valign="top"><td valign="top">YPH853<hr/></td><td valign="top">YPH491 transformed with p129CGA<hr/></td></tr><tr valign="top"><td valign="top">YPH854<hr/></td><td valign="top">YPH491 transformed with p129CGV<hr/></td></tr><tr valign="top"><td valign="top">YPH855<hr/></td><td valign="top">YPH491 transformed with p129CKR<hr/></td></tr><tr valign="top"><td valign="top">YPH862<hr/></td><td valign="top"><italic>MAT</italic>&#x003b1;, <italic>ura3-52</italic>, <italic>lys2-801</italic>, <italic>ade2-101</italic>, <italic>his3</italic>-&#x00394;<italic>200</italic>, <italic>trp1</italic>&#x00394;<italic>1</italic>, <italic>leu2</italic>-&#x00394;<italic>1</italic>, <italic>chl1</italic>&#x00394;<italic>1::HIS3</italic>, <italic>CFVII (RAD2.d.YPH275) TRP1 SUP11</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH863<hr/></td><td valign="top">YPH864 <italic>chl1</italic>-&#x00394;<italic>1::HIS3</italic>&#x0002f;<italic>chl1</italic>-&#x00394;<italic>1::URA3 pRS317LYS2</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH864<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 pRS316URA3 CHL1</italic>&#x0002f;<italic>CHL1 CAC (</italic>&#x003bb;<italic>.50kb.YPHS133) TRP1 SUP11</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH865<hr/></td><td valign="top">YPH866 <italic>chl1</italic>-&#x00394;<italic>1::HIS3</italic>&#x0002f;<italic>chl</italic>-&#x00394;<italic>1::URA3</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH866<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 pRS317LYS2 CHL1</italic>&#x0002f;<italic>CHL1 CAC (</italic>&#x003bb;<italic>.100kb.YPHS138) TRP1 SUP11 URA3</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH867<hr/></td><td valign="top">YPH868 <italic>chl1</italic>-&#x00394;<italic>1::HIS3</italic>&#x0002f;<italic>chl1</italic>-&#x00394;<italic>1::TRP1</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH868<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 TRP1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 CHL1</italic>&#x0002f;<italic>CHL1 CIII (HMR HML.355kb.YPHS187) URA3 SUP11</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH869<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 chl1</italic>-&#x00394;<italic>1::HIS3</italic>&#x0002f;<italic>chl1</italic>-&#x00394;<italic>1::TRP1 pYCP50 URA3 SUP11</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH870<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 CHL1</italic>&#x0002f;<italic>CHL1 pRS317LYS2 pYCP50 URA3 SUP11</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH871<hr/></td><td valign="top">YPH872 <italic>chl1</italic>-&#x00394;<italic>1::TRP1</italic>&#x0002f;<italic>chl1</italic>-&#x00394;<italic>1::URA3</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH872<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 CHL1</italic>&#x0002f;<italic>CHL1 LAC (H.75kb.YBP304) CEN4 URA3 SUP11 HIS3</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH873<hr/></td><td valign="top">YPH874 <italic>chl1</italic>-&#x00394;<italic>1::TRP1</italic>&#x0002f;<italic>chl1</italic>-&#x00394;<italic>1::URA3</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH874<hr/></td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 CHL1</italic>&#x0002f;<italic>CHL1 LAC (H.225kb.YBP321) CEN4 URA3 SUP11 HIS3</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH875<hr/></td><td valign="top">YPH876 <italic>chl1</italic>-&#x00394;<italic>1::TRP1</italic>&#x0002f;<italic>chl1</italic>-&#x00394;<italic>1::URA3</italic><hr/></td></tr><tr valign="top"><td valign="top">YPH876</td><td valign="top"><italic>Mata</italic>&#x0002f;<italic>Mat</italic>&#x003b1; <italic>ura3-52</italic>&#x0002f;<italic>ura3-52 lys2-801</italic>&#x0002f;<italic>lys2-801 ade2-101</italic>&#x0002f;<italic>ade2-101 his3</italic>-&#x00394;<italic>200</italic>&#x0002f;<italic>his3</italic>-&#x00394;<italic>200 trp1</italic>-&#x00394;<italic>1</italic>&#x0002f;<italic>trp1</italic>-&#x00394;<italic>1 LEU2</italic>&#x0002f;<italic>leu2</italic>-&#x00394;<italic>1 CHL1</italic>&#x0002f;<italic>CHL1 LAC (H.360kb.YBP364) CEN4 URA3 SUP11 HIS3</italic></td></tr></tbody></table></table-wrap><table-wrap id="gkd476tb2"><label>Table 2.</label><caption><title>Analysis of chromosome missegregation rates in <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> and <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids</title></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col/><col/><col/><col/><col/></colgroup><thead valign="bottom"><tr valign="top"><th valign="top">Structure</th><th valign="top">Length (kb)</th><th valign="top">Absolute missegregation rate in <italic>CHL1</italic>&#x0002f;<italic>CHL1</italic> diploids</th><th valign="top">Absolute missegregation rate in <italic>chl1</italic>&#x00394;<italic>1</italic>&#x0002f;<italic>chl1</italic>&#x00394;<italic>1</italic> diploids</th><th valign="top">Fold effect</th></tr></thead><tbody valign="top"><tr valign="top"><td valign="top">Circle<hr/></td><td valign="top">10<hr/></td><td valign="top">7.9 &#x000d7; 10&#x02013;<sup>2</sup><hr/></td><td valign="top">1.5 &#x000d7; 10&#x02013;<sup>1</sup><hr/></td><td valign="top">2<hr/></td></tr><tr valign="top"><td valign="top">Circle<hr/></td><td valign="top">50<hr/></td><td valign="top">9.0 &#x000d7; 10&#x02013;<sup>3</sup><hr/></td><td valign="top">1.5 &#x000d7; 10&#x02013;<sup>1</sup><hr/></td><td valign="top">16<hr/></td></tr><tr valign="top"><td valign="top">Circle<hr/></td><td valign="top">100<hr/></td><td valign="top">4.6 &#x000d7; 10&#x02013;<sup>3</sup><hr/></td><td valign="top">1.5 &#x000d7; 10&#x02013;<sup>1</sup><hr/></td><td valign="top">33<hr/></td></tr><tr valign="top"><td valign="top">Circle III<hr/></td><td valign="top">335<hr/></td><td valign="top">4.2 &#x000d7; 10&#x02013;<sup>4</sup><hr/></td><td valign="top">1.2 &#x000d7; 10&#x02013;<sup>3</sup><hr/></td><td valign="top">3<hr/></td></tr><tr valign="top"><td valign="top">Human DNA<hr/></td><td valign="top">&#x000a0;<hr/></td><td valign="top">&#x000a0;<hr/></td><td valign="top">&#x000a0;<hr/></td><td valign="top">&#x000a0;<hr/></td></tr><tr valign="top"><td valign="top">Linear HYAC<hr/></td><td valign="top">75<hr/></td><td valign="top">4.2 &#x000d7; 10&#x02013;<sup>4</sup><hr/></td><td valign="top">1.4 &#x000d7; 10&#x02013;<sup>1</sup><hr/></td><td valign="top">340<hr/></td></tr><tr valign="top"><td valign="top">Linear HYAC<hr/></td><td valign="top">225<hr/></td><td valign="top">4.9 &#x000d7; 10&#x02013;<sup>4</sup><hr/></td><td valign="top">3.8 &#x000d7; 10&#x02013;<sup>3</sup><hr/></td><td valign="top">8<hr/></td></tr><tr valign="top"><td valign="top">Linear HYAC<hr/></td><td valign="top">360<hr/></td><td valign="top">2.7 &#x000d7; 10&#x02013;<sup>3</sup><hr/></td><td valign="top">7.3 &#x000d7; 10&#x02013;<sup>3</sup><hr/></td><td valign="top">3<hr/></td></tr><tr valign="top"><td valign="top">Yeast DNA<hr/></td><td valign="top">&#x000a0;<hr/></td><td valign="top">&#x000a0;<hr/></td><td valign="top">&#x000a0;<hr/></td><td valign="top">&#x000a0;<hr/></td></tr><tr valign="top"><td valign="top">CEN 3L<hr/></td><td valign="top">145<hr/></td><td valign="top">4.0 &#x000d7; 10&#x02013;<sup>4</sup><hr/></td><td valign="top">1.0 &#x000d7; 10&#x02013;<sup>1</sup><hr/></td><td valign="top">3000<hr/></td></tr><tr valign="top"><td valign="top">CHR III</td><td valign="top">365</td><td valign="top">1.5 &#x000d7; 10&#x02013;<sup>5</sup></td><td valign="top">3.1 &#x000d7; 10&#x02013;<sup>3</sup></td><td valign="top">210</td></tr></tbody></table></table-wrap></sec><ack><sec><title>ACKNOWLEDGEMENTS</title><p>I would like to thank Phil Hieter for reagents, helpful advice and a great research environment within which this work was initiated. I would also like to thank M. McCormick for providing YACs, W. Pavan and R. Reeves for YAC deletion derivatives, J. Aris for D77 antibodies, and Carla Connelly for technical input. S.H. is supported by the Howard Hughes Medical Institute.</p></sec></ack><ref-list><title>REFERENCES</title><ref id="gkd476c1"><label>1.</label><citation citation-type="journal"><name><surname>Haber</surname><given-names>J.E.</given-names></name> (1974) <source>Genetics</source>, <volume>78</volume>, <fpage>843</fpage>&#x02013;<lpage>858</lpage>.<pub-id pub-id-type="pmid">4615978</pub-id></citation></ref><ref id="gkd476c2"><label>2.</label><citation citation-type="journal"><name><surname>Liras</surname><given-names>P.</given-names></name>, McCusker,J., Mascioli,S. and Haber,J. (1978) <source>Genetics</source>, <volume>88</volume>, <fpage>651</fpage>&#x02013;<lpage>671</lpage>.</citation></ref><ref id="gkd476c3"><label>3.</label><citation citation-type="journal"><name><surname>Spencer</surname><given-names>F.</given-names></name>, Gerring,S.L., Connelly,C. and Hieter,P. (1990) <source>Genetics</source>, <volume>124</volume>, <fpage>237</fpage>&#x02013;<lpage>249</lpage>.<pub-id pub-id-type="pmid">2407610</pub-id></citation></ref><ref id="gkd476c4"><label>4.</label><citation citation-type="journal"><name><surname>Hieter</surname><given-names>P.</given-names></name>, Mann,C., Snyder,M. and Davis,R.W. (1985) <source>Cell</source>, <volume>40</volume>, <fpage>381</fpage>&#x02013;<lpage>392</lpage>.<pub-id pub-id-type="pmid">3967296</pub-id></citation></ref><ref id="gkd476c5"><label>5.</label><citation citation-type="journal"><name><surname>Murray</surname><given-names>A.W.</given-names></name>, Schultes,N.P. and Szostak,J.W. (1986) <source>Cell</source>, <volume>45</volume>, <fpage>529</fpage>&#x02013;<lpage>536</lpage>.<pub-id pub-id-type="pmid">3518944</pub-id></citation></ref><ref id="gkd476c6"><label>6.</label><citation citation-type="journal"><name><surname>Murray</surname><given-names>A.W.</given-names></name> and Szostak,J.W. (1983) <source>Nature</source>, <volume>305</volume>, <fpage>189</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">6350893</pub-id></citation></ref><ref id="gkd476c7"><label>7.</label><citation citation-type="journal"><name><surname>Weiler</surname><given-names>K.S.</given-names></name>, Szeto,L. and Broach,J.R. (1995) <source>Genetics</source>, <volume>139</volume>, <fpage>1495</fpage>&#x02013;<lpage>1510</lpage>.<pub-id pub-id-type="pmid">7789755</pub-id></citation></ref><ref id="gkd476c8"><label>8.</label><citation citation-type="journal"><name><surname>Gerring</surname><given-names>S.L.</given-names></name>, Spencer,F. and Hieter,P. (1990) <source>EMBO J.</source>, <volume>9</volume>, <fpage>4347</fpage>&#x02013;<lpage>4358</lpage>.<pub-id pub-id-type="pmid">2265610</pub-id></citation></ref><ref id="gkd476c9"><label>9.</label><citation citation-type="journal"><name><surname>Reynolds</surname><given-names>P.</given-names></name>, Higgins,D.R., Prakash,L. and Prakash,S. (1985) <source>Nucleic Acids Res.</source>, <volume>13</volume>, <fpage>2357</fpage>&#x02013;<lpage>2372</lpage>.<pub-id pub-id-type="pmid">2987851</pub-id></citation></ref><ref id="gkd476c10"><label>10.</label><citation citation-type="journal"><name><surname>Naumovski</surname><given-names>L.</given-names></name>, Chu,G., Berg,P. and Friedberg,E.C. (1985) <source>Mol. Cell. Biol.</source>, <volume>5</volume>, <fpage>17</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">3885009</pub-id></citation></ref><ref id="gkd476c11"><label>11.</label><citation citation-type="journal"><name><surname>Friedberg</surname><given-names>E.C.</given-names></name> (1988) <source>Microbiol. Rev.</source>, <volume>42</volume>, <fpage>70</fpage>&#x02013;<lpage>102</lpage>.</citation></ref><ref id="gkd476c12"><label>12.</label><citation citation-type="journal"><name><surname>Walker</surname><given-names>J.E.</given-names></name>, Saraste,M., Runswick,M.J. and Gay,N.J. (1982) <source>EMBO J.</source>, <volume>1</volume>, <fpage>945</fpage>&#x02013;<lpage>951</lpage>.<pub-id pub-id-type="pmid">6329717</pub-id></citation></ref><ref id="gkd476c13"><label>13.</label><citation citation-type="journal"><name><surname>Saraste</surname><given-names>M.</given-names></name>, Sibbald,P.R. and Wittinghofer,A. (1990) <source>Trends Biochem. Sci.</source>, <volume>15</volume>, <fpage>430</fpage>&#x02013;<lpage>434</lpage>.<pub-id pub-id-type="pmid">2126155</pub-id></citation></ref><ref id="gkd476c14"><label>14.</label><citation citation-type="journal"><name><surname>Pabo</surname><given-names>C.</given-names></name> and Sauer,R. (1984) <source>Annu. Rev. Biochem.</source>, <volume>53</volume>, <fpage>293</fpage>&#x02013;<lpage>321</lpage>.<pub-id pub-id-type="pmid">6236744</pub-id></citation></ref><ref id="gkd476c15"><label>15.</label><citation citation-type="journal"><name><surname>Gorbalenya</surname><given-names>A.E.</given-names></name> and Koonin,E.V. (1993) <source>Curr. Opin. Struct. Biol.</source>, <volume>3</volume>, <fpage>419</fpage>&#x02013;<lpage>429</lpage>.</citation></ref><ref id="gkd476c16"><label>16.</label><citation citation-type="journal"><name><surname>Koonin</surname><given-names>E.V.</given-names></name> (1993) <source>Nucleic Acids Res.</source>, <volume>21</volume>, <fpage>1497</fpage>.<pub-id pub-id-type="pmid">8385320</pub-id></citation></ref><ref id="gkd476c17"><label>17.</label><citation citation-type="journal"><name><surname>Amann</surname><given-names>J.</given-names></name>, Kidd,V.J. and Lahti,J.M. (1997) <source>J. Biol. Chem.</source>, <volume>272</volume>, <fpage>3823</fpage>&#x02013;<lpage>3832</lpage>.<pub-id pub-id-type="pmid">9013641</pub-id></citation></ref><ref id="gkd476c18"><label>18.</label><citation citation-type="journal"><name><surname>Hirota</surname><given-names>Y.</given-names></name> and Lahti,J.M. (2000) <source>Nucleic Acids Res.</source>, <volume>28</volume>, <fpage>917</fpage>&#x02013;<lpage>924</lpage>.<pub-id pub-id-type="pmid">10648783</pub-id></citation></ref><ref id="gkd476c19"><label>19.</label><citation citation-type="journal"><name><surname>Amann</surname><given-names>J.</given-names></name>, Valentine,M., Kidd,V.J. and Lahti,J.M. (1996) <source>Genomics</source>, <volume>32</volume>, <fpage>260</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">8833153</pub-id></citation></ref><ref id="gkd476c20"><label>20.</label><citation citation-type="journal"><name><surname>Frank</surname><given-names>S.</given-names></name> and Werner,S. (1996) <source>J. Biol. Chem.</source>, <volume>271</volume>, <fpage>24337</fpage>&#x02013;<lpage>24340</lpage>.<pub-id pub-id-type="pmid">8798685</pub-id></citation></ref><ref id="gkd476c21"><label>21.</label><citation citation-type="journal"><name><surname>Sung</surname><given-names>P.</given-names></name>, Prakash,L., Matson,S.W. and Prakash,S. (1987) <source>Proc. Natl Acad. Sci. USA</source>, <volume>84</volume>, <fpage>8951</fpage>&#x02013;<lpage>8955</lpage>.<pub-id pub-id-type="pmid">2827162</pub-id></citation></ref><ref id="gkd476c22"><label>22.</label><citation citation-type="journal"><name><surname>Sung</surname><given-names>P.</given-names></name>, Prakash,L., Weber,S. and Prakash,S. (1987) <source>Proc. Natl Acad. Sci. USA</source>, <volume>84</volume>, <fpage>6045</fpage>&#x02013;<lpage>6049</lpage>.<pub-id pub-id-type="pmid">2957691</pub-id></citation></ref><ref id="gkd476c23"><label>23.</label><citation citation-type="journal"><name><surname>Harosh</surname><given-names>I.</given-names></name>, Naumovski,L. and Freidberg,E.C. (1989) <source>J. Biol. Chem.</source>, <volume>264</volume>, <fpage>20532</fpage>&#x02013;<lpage>20539</lpage>.<pub-id pub-id-type="pmid">2555362</pub-id></citation></ref><ref id="gkd476c24"><label>24.</label><citation citation-type="journal"><name><surname>Sung</surname><given-names>P.</given-names></name>, Higgins,D., Prakash,L. and Prakash,S. (1988) <source>EMBO J.</source>, <volume>7</volume>, <fpage>3263</fpage>&#x02013;<lpage>3269</lpage>.<pub-id pub-id-type="pmid">2846277</pub-id></citation></ref><ref id="gkd476c25"><label>25.</label><citation citation-type="journal"><name><surname>Li</surname><given-names>R.</given-names></name> and Murray,A.W. (1991) <source>Cell</source>, <volume>66</volume>, <fpage>519</fpage>&#x02013;<lpage>531</lpage>.<pub-id pub-id-type="pmid">1651172</pub-id></citation></ref><ref id="gkd476c26"><label>26.</label><citation citation-type="journal"><name><surname>Sikorski</surname><given-names>R.S.</given-names></name> and Hieter,P. (1989) <source>Genetics</source>, <volume>122</volume>, <fpage>19</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">2659436</pub-id></citation></ref><ref id="gkd476c27"><label>27.</label><citation citation-type="other"><name><surname>Sherman</surname><given-names>F.</given-names></name>, Fink,G.R. and Hicks,J.B. (1986) In Press,C.S.H.L. (ed.), <italic>Methods in Yeast Genetics</italic>. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 1&#x02013;186.</citation></ref><ref id="gkd476c28"><label>28.</label><citation citation-type="journal"><name><surname>Johnston</surname><given-names>H.M.</given-names></name> and Davis,R. (1984) <source>Mol. Cell. Biol.</source>, <volume>4</volume>, <fpage>1440</fpage>&#x02013;<lpage>1448</lpage>.<pub-id pub-id-type="pmid">6092912</pub-id></citation></ref><ref id="gkd476c29"><label>29.</label><citation citation-type="journal"><name><surname>Dieckmann</surname><given-names>C.L.</given-names></name> and Tzagoloff,A. (1985) <source>J. Biol. Chem.</source>, <volume>260</volume>, <fpage>1513</fpage>&#x02013;<lpage>1520</lpage>.<pub-id pub-id-type="pmid">2981859</pub-id></citation></ref><ref id="gkd476c30"><label>30.</label><citation citation-type="journal"><name><surname>Koerner</surname><given-names>T.J.</given-names></name>, Hill,J.E., Myers,A. and Tzagaloff,A. (1991) <source>Methods Enzymol.</source>, <volume>194</volume>, <fpage>477</fpage>&#x02013;<lpage>490</lpage>.<pub-id pub-id-type="pmid">2005804</pub-id></citation></ref><ref id="gkd476c31"><label>31.</label><citation citation-type="journal"><name><surname>Kunkel</surname><given-names>T.A.</given-names></name> (1985) <source>Proc. Natl Acad. Sci. USA</source>, <volume>82</volume>, <fpage>488</fpage>&#x02013;<lpage>492</lpage>.<pub-id pub-id-type="pmid">3881765</pub-id></citation></ref><ref id="gkd476c32"><label>32.</label><citation citation-type="journal"><name><surname>Ito</surname><given-names>H.</given-names></name>, Fukuda,Y., Murata,K. and Kimura,A. (1983) <source>J. Bacteriol</source>., <volume>153</volume>, <fpage>163</fpage>&#x02013;<lpage>168</lpage>.<pub-id pub-id-type="pmid">6336730</pub-id></citation></ref><ref id="gkd476c33"><label>33.</label><citation citation-type="journal"><name><surname>Kleid</surname><given-names>D.G.</given-names></name>, Yansura,D., Small,B., Dowbenko,D., Moore,D.M., Grubman,M.J., McKercher,P.D., Morgan,D.O., Robertson,B.H. and Bachrach,H.L. (1981) <source>Science</source>, <volume>214</volume>, <fpage>1125</fpage>&#x02013;<lpage>1129</lpage>.<pub-id pub-id-type="pmid">6272395</pub-id></citation></ref><ref id="gkd476c34"><label>34.</label><citation citation-type="journal"><name><surname>Spindler</surname><given-names>K.S.</given-names></name>, Rosser,D.S.E. and Berk,A.J. (1984) <source>J. Virol.</source>, <volume>49</volume>, <fpage>132</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">6361277</pub-id></citation></ref><ref id="gkd476c35"><label>35.</label><citation citation-type="journal"><name><surname>Doolittle</surname><given-names>W.F.</given-names></name> and Yanofsky,C. (1968) <source>J. Bacteriol</source>., <volume>95</volume>, <fpage>1283</fpage>&#x02013;<lpage>1284</lpage>.<pub-id pub-id-type="pmid">4869215</pub-id></citation></ref><ref id="gkd476c36"><label>36.</label><citation citation-type="other"><name><surname>Harlow</surname><given-names>E.</given-names></name> and Lane,D. (1988) <italic>Antibodies: A Laboratory Manual</italic>. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.</citation></ref><ref id="gkd476c37"><label>37.</label><citation citation-type="journal"><name><surname>Amati</surname><given-names>B.B.</given-names></name> and Gasser,S.M. (1988) <source>Cell</source>, <volume>54</volume>, <fpage>967</fpage>&#x02013;<lpage>978</lpage>.<pub-id pub-id-type="pmid">2843296</pub-id></citation></ref><ref id="gkd476c38"><label>38.</label><citation citation-type="journal"><name><surname>Lowry</surname><given-names>O.H.</given-names></name>, Rosebrough,N.J., Farr,A.L. and Randall,R.J. (1951) <source>J. Biol. Chem.</source>, <volume>193</volume>, <fpage>265</fpage>&#x02013;<lpage>275</lpage>.<pub-id pub-id-type="pmid">14907713</pub-id></citation></ref><ref id="gkd476c39"><label>39.</label><citation citation-type="journal"><name><surname>Smith</surname><given-names>P.K.</given-names></name>, Krohn,R.I., Hermanson,G.T., Mallia,A.K., Gartner,F.H., Provenzano,M.D., Fujimoto,E.K., Goeke,N.M., Olson,B.J. and Klenk,D.C. (1985) <source>Anal. Biochem.</source>, <volume>150</volume>, <fpage>76</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">3843705</pub-id></citation></ref><ref id="gkd476c40"><label>40.</label><citation citation-type="journal"><name><surname>Peterson</surname><given-names>G.L.</given-names></name> (1977) <source>Anal. Biochem.</source>, <volume>83</volume>, <fpage>346</fpage>&#x02013;<lpage>356</lpage>.<pub-id pub-id-type="pmid">603028</pub-id></citation></ref><ref id="gkd476c41"><label>41.</label><citation citation-type="journal"><name><surname>Brown</surname><given-names>R.E.</given-names></name>, Jarvis,K.L. and Hyland,K.J. (1988) <source>Anal. Biochem.</source>, <volume>180</volume>, <fpage>136</fpage>&#x02013;<lpage>139</lpage>.</citation></ref><ref id="gkd476c42"><label>42.</label><citation citation-type="journal"><name><surname>Bensadoun</surname><given-names>A.</given-names></name> and Weinstein,D. (1976) <source>Anal. Biochem.</source>, <volume>70</volume>, <fpage>241</fpage>&#x02013;<lpage>250</lpage>.<pub-id pub-id-type="pmid">1259145</pub-id></citation></ref><ref id="gkd476c43"><label>43.</label><citation citation-type="journal"><name><surname>Aris</surname><given-names>J.P.</given-names></name> and Blobel,G. (1988) <source>J. Cell Biol.</source>, <volume>107</volume>, <fpage>17</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">3292539</pub-id></citation></ref><ref id="gkd476c44"><label>44.</label><citation citation-type="journal"><name><surname>Olmsted</surname><given-names>J.B.</given-names></name> (1981) <source>J. Biol. Chem.</source>, <volume>256</volume>, <fpage>11955</fpage>&#x02013;<lpage>11957</lpage>.<pub-id pub-id-type="pmid">7028745</pub-id></citation></ref><ref id="gkd476c45"><label>45.</label><citation citation-type="journal"><name><surname>Koshland</surname><given-names>D.</given-names></name> and Hieter,P. (1987) <source>Methods Enzymol.</source>, <volume>155</volume>, <fpage>351</fpage>&#x02013;<lpage>372</lpage>.<pub-id pub-id-type="pmid">3431466</pub-id></citation></ref><ref id="gkd476c46"><label>46.</label><citation citation-type="journal"><name><surname>Hegemann</surname><given-names>J.H.</given-names></name>, Shero,J.H., Cottarel,G., Philippsen,P. and Hieter,P. (1988) <source>Mol. Cell. Biol.</source>, <volume>8</volume>, <fpage>2523</fpage>&#x02013;<lpage>2535</lpage>.<pub-id pub-id-type="pmid">3043181</pub-id></citation></ref><ref id="gkd476c47"><label>47.</label><citation citation-type="journal"><name><surname>Lea</surname><given-names>D.</given-names></name> and Coulson,C. (1949) <source>J. Genet.</source>, <volume>49</volume>, <fpage>264</fpage>&#x02013;<lpage>285</lpage>.</citation></ref><ref id="gkd476c48"><label>48.</label><citation citation-type="journal"><name><surname>Pavan</surname><given-names>W.J.</given-names></name>, Hieter,P. and Reeves,R.H. (1990) <source>Proc. Natl Acad. Sci. USA</source>, <volume>87</volume>, <fpage>1300</fpage>&#x02013;<lpage>1304</lpage>.<pub-id pub-id-type="pmid">2406718</pub-id></citation></ref><ref id="gkd476c49"><label>49.</label><citation citation-type="journal"><name><surname>Sigal</surname><given-names>I.S.</given-names></name>, Gibbs,J.B., D&#x02019;Alonzo,J.S., Temeles,G.L., Wolanski,B.S., Socher,S.H. and Scolnick,E.M. (1986) <source>Proc. Natl Acad. Sci. USA</source>, <volume>83</volume>, <fpage>952</fpage>&#x02013;<lpage>956</lpage>.<pub-id pub-id-type="pmid">3513168</pub-id></citation></ref><ref id="gkd476c50"><label>50.</label><citation citation-type="journal"><name><surname>Haber</surname><given-names>J.E.</given-names></name>, Thorburn,P.C. and Rogers,D. (1984) <source>Genetics</source>, <volume>106</volume>, <fpage>185</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">6321297</pub-id></citation></ref><ref id="gkd476c51"><label>51.</label><citation citation-type="journal"><name><surname>Azzaria</surname><given-names>M.</given-names></name>, Schurr,E. and Gros,P. (1989) <source>Mol. Cell. Biol.</source>, <volume>9</volume>, <fpage>5289</fpage>&#x02013;<lpage>5297</lpage>.<pub-id pub-id-type="pmid">2573836</pub-id></citation></ref><ref id="gkd476c52"><label>52.</label><citation citation-type="journal"><name><surname>Rao</surname><given-names>R.</given-names></name>, Pagan,J. and Senior,A. (1988) <source>J. Biol. Chem.</source>, <volume>263</volume>, <fpage>15957</fpage>&#x02013;<lpage>15963</lpage>.<pub-id pub-id-type="pmid">2903146</pub-id></citation></ref><ref id="gkd476c53"><label>53.</label><citation citation-type="journal"><name><surname>Honegger</surname><given-names>A.M.</given-names></name>, Dull,T.J., Felder,S., van Obberghen,E., Bellot,F., Szapary,D., Schmidt,A., Ullrich,A. and Schlessinger,J. (1987) <source>Cell</source>, <volume>51</volume>, <fpage>199</fpage>&#x02013;<lpage>209</lpage>.<pub-id pub-id-type="pmid">3499230</pub-id></citation></ref><ref id="gkd476c54"><label>54.</label><citation citation-type="journal"><name><surname>Chou</surname><given-names>C.K.</given-names></name>, Dull,T.J., Russel,D.S., Gherzi,R., Lebwohl,D., Ullrich,A. and Rosen,O.M. (1987) <source>J. Biol. Chem.</source>, <volume>262</volume>, <fpage>1842</fpage>&#x02013;<lpage>1847</lpage>.<pub-id pub-id-type="pmid">3100537</pub-id></citation></ref><ref id="gkd476c55"><label>55.</label><citation citation-type="journal"><name><surname>Dombroski</surname><given-names>A.J.</given-names></name>, Brennan,C.A., Spear,P. and Platt,T. (1988) <source>J. Biol. Chem.</source>, <volume>263</volume>, <fpage>18802</fpage>&#x02013;<lpage>18809</lpage>.<pub-id pub-id-type="pmid">2461932</pub-id></citation></ref><ref id="gkd476c56"><label>56.</label><citation citation-type="journal"><name><surname>Surosky</surname><given-names>R.T.</given-names></name>, Newlon,C.S. and Tye,B.K. (1986) <source>Proc. Natl Acad. Sci. USA</source>, <volume>83</volume>, <fpage>414</fpage>&#x02013;<lpage>418</lpage>.<pub-id pub-id-type="pmid">3510434</pub-id></citation></ref><ref id="gkd476c57"><label>57.</label><citation citation-type="journal"><name><surname>Palmer</surname><given-names>R.E.</given-names></name>, Hogan,E. and Koshland,D. (1990) <source>Genetics</source>, <volume>125</volume>, <fpage>763</fpage>&#x02013;<lpage>774</lpage>.<pub-id pub-id-type="pmid">2204582</pub-id></citation></ref><ref id="gkd476c58"><label>58.</label><citation citation-type="journal"><name><surname>Hartwell</surname><given-names>L.H.</given-names></name> and Smith,D. (1985) <source>Genetics</source>, <volume>110</volume>, <fpage>381</fpage>&#x02013;<lpage>395</lpage>.<pub-id pub-id-type="pmid">3894160</pub-id></citation></ref><ref id="gkd476c59"><label>59.</label><citation citation-type="journal"><name><surname>Conrad</surname><given-names>M.N.</given-names></name>, Wright,J.H., Wolf,A.J. and Zakian,V.A. (1990) <source>Cell</source>, <volume>63</volume>, <fpage>739</fpage>&#x02013;<lpage>750</lpage>.<pub-id pub-id-type="pmid">2225074</pub-id></citation></ref><ref id="gkd476c60"><label>60.</label><citation citation-type="journal"><name><surname>Wells</surname><given-names>W.A.E.</given-names></name> and Murray,A.W. (1996) <source>J. Cell Biol.</source>, <volume>133</volume>, <fpage>75</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">8601615</pub-id></citation></ref><ref id="gkd476c61"><label>61.</label><citation citation-type="journal"><name><surname>Hardwick</surname><given-names>K.G.</given-names></name> (1998) <source>Trends Genet.</source>, <volume>14</volume>, <fpage>1</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">9448456</pub-id></citation></ref><ref id="gkd476c62"><label>62.</label><citation citation-type="journal"><name><surname>Amon</surname><given-names>A.</given-names></name> (1999) <source>Curr. Opin. Genet. Dev.</source>, <volume>9</volume>, <fpage>69</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">10072359</pub-id></citation></ref><ref id="gkd476c63"><label>63.</label><citation citation-type="journal"><name><surname>Gorbsky</surname><given-names>G.J.</given-names></name> (1997) <source>Bioessays</source>, <volume>19</volume>, <fpage>193</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="pmid">9103187</pub-id></citation></ref><ref id="gkd476c64"><label>64.</label><citation citation-type="journal"><name><surname>Rieder</surname><given-names>C.L.</given-names></name> and Salmon,E.D. (1998) <source>Trends Cell Biol.</source>, <volume>8</volume>, <fpage>310</fpage>&#x02013;<lpage>318</lpage>.<pub-id pub-id-type="pmid">9704407</pub-id></citation></ref><ref id="gkd476c65"><label>65.</label><citation citation-type="journal"><name><surname>Spell</surname><given-names>R.M.</given-names></name> and Holm,C. (1994) <source>Mol. Cell. Biol.</source>, <volume>14</volume>, <fpage>1465</fpage>&#x02013;<lpage>1476</lpage>.<pub-id pub-id-type="pmid">8289822</pub-id></citation></ref><ref id="gkd476c66"><label>66.</label><citation citation-type="journal"><name><surname>Koshland</surname><given-names>D.</given-names></name> and Hartwell,L.H. (1987) <source>Science</source>, <volume>238</volume>, <fpage>1713</fpage>&#x02013;<lpage>1716</lpage>.<pub-id pub-id-type="pmid">3317838</pub-id></citation></ref><ref id="gkd476c67"><label>67.</label><citation citation-type="journal"><name><surname>Nasmyth</surname><given-names>K.</given-names></name> (1999) <source>Trends Biochem. Sci.</source>, <volume>24</volume>, <fpage>98</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">10203756</pub-id></citation></ref><ref id="gkd476c68"><label>68.</label><citation citation-type="journal"><name><surname>Sudin</surname><given-names>O.</given-names></name> and Varshavsky,A. (1981) <source>Cell</source>, <volume>25</volume>, <fpage>659</fpage>&#x02013;<lpage>669</lpage>.<pub-id pub-id-type="pmid">6269752</pub-id></citation></ref><ref id="gkd476c69"><label>69.</label><citation citation-type="journal"><name><surname>Heck</surname><given-names>M.M.S.</given-names></name> (1997) <source>Cell</source>, <volume>91</volume>, <fpage>5</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">9335328</pub-id></citation></ref></ref-list></back></article> 